Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: Impact of a dose-modification guideline
- Paul G. Richardson
- , Pieter Sonneveld
- , Michael W. Schuster
- , Edward A. Stadtmauer
- , Thierry Facon
- , Jean Luc Harousseau
- , Dina Ben-Yehuda
- , Sagar Lonial
- , Hartmut Goldschmidt
- , Donna Reece
- , Joan Bladé
- , Mario Boccadoro
- , Jamie D. Cavenagh
- , Anthony L. Boral
- , Dixie Lee Esseltine
- , Patrick Y. Wen
- , Anthony A. Amato
- , Kenneth C. Anderson
- , Jesus San Miguel
Research output: Contribution to journal › Article › peer-review
280
Scopus
citations